ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

January 30, 2009

HHS Draft of Bill Reauthorizing NIH Specifically Kills Bypass Budget, Would End National Cancer Act of 1971

March 29, 1985

Battelle Wins Big Toxiology Contract

March 22, 1974

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

Space Station Attacked By Health Research Advocates on Earth

May 8, 1992

Funding Opportunities: CAM Research Center Applications Sought.

January 3, 2003